Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

par Berton, A. M., Prencipe, N., Giordano, R., Ghigo, E., Grottoli, S.
Publié dans J Endocrinol Invest (2020)

Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment

par Prencipe, N., Bona, C., Cuboni, D., Parasiliti-Caprino, M., Berton, A. M., Fenoglio, L. M., Gasco, V., Ghigo, E., Grottoli, S.
Publié dans Pituitary (2020)

Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study

par Beccuti, G., Guaraldi, F., Natta, G., Cambria, V., Prencipe, N., Cicolin, A., Montanaro, E., Lopiano, L., Ghigo, E., Zibetti, M., Grottoli, S.
Publié dans J Endocrinol Invest (2020)

Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass

par Pasero, D., Berton, A. M., Motta, G., Raffaldi, R., Fornaro, G., Costamagna, A., Toscano, A., Filippini, C., Mengozzi, G., Prencipe, N., Zavattaro, M., Settanni, F., Ghigo, E., Brazzi, L., Benso, A. S.
Publié dans J Endocrinol Invest (2020)